RA Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Hold |
14,932,063
| – | – | 0.29% | 37 |
|
|
2025
Q1 | $16.4M | Hold |
14,932,063
| – | – | 0.27% | 50 |
|
|
2024
Q4 | $25.7M | Hold |
14,932,063
| – | – | 0.34% | 48 |
|
|
2024
Q3 | $37M | Hold |
14,932,063
| – | – | 0.43% | 45 |
|
|
2024
Q2 | $36.1M | Hold |
14,932,063
| – | – | 0.48% | 44 |
|
|
2024
Q1 | $60.5M | Hold |
14,932,063
| – | – | 0.77% | 36 |
|
|
2023
Q4 | $57.3M | Hold |
14,932,063
| – | – | 0.9% | 27 |
|
|
2023
Q3 | $62M | Buy |
14,932,063
+5,161,290
| +53% | +$21.4M | 1.22% | 24 |
|
|
2023
Q2 | $47M | Hold |
9,770,773
| – | – | 0.89% | 33 |
|
|
2023
Q1 | $39.7M | Hold |
9,770,773
| – | – | 0.9% | 34 |
|
|
2022
Q4 | $52.8M | Hold |
9,770,773
| – | – | 1.07% | 28 |
|
|
2022
Q3 | $98M | Hold |
9,770,773
| – | – | 2.09% | 15 |
|
|
2022
Q2 | $45.9M | Hold |
9,770,773
| – | – | 1.22% | 27 |
|
|
2022
Q1 | $38.2M | Hold |
9,770,773
| – | – | 0.83% | 38 |
|
|
2021
Q4 | $66.1M | Hold |
9,770,773
| – | – | 1.16% | 24 |
|
|
2021
Q3 | $145M | Buy |
+9,770,773
| New | +$145M | 2.01% | 15 |
|